Longitudinal changes in rheumatoid arthritis after rituximab administration assessed by quantitative and dynamic contrast-enhanced 3-T MR imaging: Preliminary findings

European Radiology

Volumn 19, Issue 9, 2009, Pages 2217-2224

  Fritz, Jan ^a,b   Galeczko, Eva K ^a   Schwenzer, Nina ^a   Fenchel, Michael ^a   Claussen, Claus D ^a   Carrino, John A ^b   Horger, Marius S ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dynamic contrast enhanced MR imaging; High field MR imaging; Magnetic resonance imaging; Rheumatoid arthritis; Rituximab

Indexed keywords

C REACTIVE PROTEIN; PREDNISOLONE; RITUXIMAB;

28 JOINT DISEASE ACTIVITY SCORE; ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE TISSUE; CONTRAST ENHANCEMENT; DRUG RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMAGE ANALYSIS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; METACARPOPHALANGEAL JOINT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE STUDY; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYNOVITIS; SYNOVIUM; THREE DIMENSIONAL IMAGING;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PILOT PROJECTS; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 68449098691     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1401-y     Document Type: Article

References (37)

1. McLaughlin P, Grillo-Lopez AJ, Link BK et al (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 16:2825-2833
2. Edwards JC, Szczepanski L, Szechinski J et al (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350:2572-2581
3. Cohen SB, Emery P, Greenwald MW et al (2006) Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 54:2793-2806
4. McQueen FM, Benton N, Perry D et al (2003) Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 48:1814-1827
5. Ostergaard M, Duer A, Nielsen H et al (2005) Magnetic resonance imaging for accelerated assessment of drug effect and prediction of subsequent radiographic progression in rheumatoid arthritis: A study of patients receiving combined anakinra and methotrexate treatment. Ann Rheum Dis 64:1503-1506
6. Palosaari K, Vuotila J, Takalo R et al (2006) Bone oedema predicts erosive progression on wrist MRI in early RA - a 2-yr observational MRI and NC scintigraphy study. Rheumatology (Oxford) 45:1542-1548
7. McQueen FM (2000) Magnetic resonance imaging in early inflammatory arthritis: What is its role? Rheumatology (Oxford) 39:700-706
8. Bird P, Lassere M, Shnier R et al (2003) Computerized measurement of magnetic resonance imaging erosion volumes in patients with rheumatoid arthritis: A comparison with existing magnetic resonance imaging scoring systems and standard clinical outcome measures. Arthritis Rheum 48:614-624
9. Ostergaard M (1997) Different approaches to synovial membrane volume determination by magnetic resonance imaging: Manual versus automated segmentation. Br J Rheumatol 36:1166-1177
10. Tam LS, Griffith JF, Yu AB et al (2007) Rapid improvement in rheumatoid arthritis patients on combination of methotrexate and infliximab: clinical and magnetic resonance imaging evaluation. Clin Rheumatol 26:941-946
11. Konig H, Sieper J, Wolf KJ (1990) Rheumatoid arthritis: Evaluation of hypervascular and fibrous pannus with dynamic MR imaging enhanced with Gd-DTPA. Radiology 176:473-477
12. Ostergaard M, Stoltenberg M, Lovgreen-Nielsen P et al (1998) Quantification of synovistis by MRI: Correlation between dynamic and static gadolinium-enhanced magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation. Magn Reson Imaging 16:743-754
13. Huang J, Stewart N, Crabbe J et al (2000) A 1-year follow-up study of dynamic magnetic resonance imaging in early rheumatoid arthritis reveals synovitis to be increased in shared epitope-positive patients and predictive of erosions at 1 year. Rheumatology (Oxford) 39:407-416
14. Hodgson R, Grainger A, O'Connor P et al (2008) Dynamic contrast enhanced MRI of bone marrow oedema in rheumatoid arthritis. Ann Rheum Dis 67:270-272
15. Polisson RP, Schoenberg OI, Fischman A et al (1995) Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Rheum 38:819-825
16. Kalden-Nemeth D, Grebmeier J, Antoni C et al (1997) NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-alpha monoclonal antibody therapy. Rheumatol Int 16:249-255
17. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
18. van der Heijde DM, van't Hof MA, van Riel PL et al (1990) Judging disease activity in clinical practice in rheumatoid arthritis: First step in the development of a disease activity score. Ann Rheum Dis 49:916-920
19. van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845-1850
20. Tamai K, Yamato M, Yamaguchi T et al (1994) Dynamic magnetic resonance imaging for the evaluation of synovitis in patients with rheumatoid arthritis. Arthritis Rheum 37:1151-1157
21. Sonnad SS (2002) Describing data: Statistical and graphical methods. Radiology 225:622-628
22. Bland JM, Altman DG (1996) Measurement error proportional to the mean. BMJ 313:106
23. Applegate KE, Tello R, Ying J (2003) Hypothesis testing III: Counts and medians. Radiology 228:603-608
24. Bland M (2000) An introduction to medical statistics. Oxford University Press, Oxford
25. Strand V, Balbir-Gurman A, Pavelka K et al (2006) Sustained benefit in rheumatoid arthritis following one course of rituximab: Improvements in physical function over 2 years. Rheumatology (Oxford) 45:1505-1513
26. McGonagle D, Tan AL, Madden J et al (2008) Rituximab use in everyday clinical practice as a first-line biologic therapy for the treatment of DMARD-resistant rheumatoid arthritis. Rheumatology (Oxford) 47:865-867
27. Argyropoulou MI, Glatzouni A, Voulgari PV et al (2005) Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with infliximab. Joint Bone Spine 72:557-561
28. Palmer WE, Rosenthal DI, Schoenberg OI et al (1995) Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy- D -glucose. Radiology 196:647-655
29. Ostergaard M, Stoltenberg M, Lovgreen-Nielsen P et al (1997) Magnetic resonance imaging-determined synovial membrane and joint effusion volumes in rheumatoid arthritis and osteoarthritis: Comparison with the macroscopic and microscopic appearance of the synovium. Arthritis Rheum 40:1856-1867
30. Ostergaard M, Hansen M, Stoltenberg M et al (1999) Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum 42:918-929
31. Jimenez-Boj E, Nobauer-Huhmann I, Hanslik-Schnabel B et al (2007) Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 56:1118-1124
32. Haavardsholm EA, Boyesen P, Ostergaard M et al (2008) Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: Bone marrow oedema predicts erosive progression. Ann Rheum Dis 67:794-800
33. Savnik A, Malmskov H, Thomsen HS et al (2002) MRI of the wrist and finger joints in inflammatory joint diseases at 1-year interval: MRI features to predict bone erosions. Eur Radiol 12:1203-1210
34. McQueen FM, Stewart N, Crabbe J et al (1999) Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis 58:156-163
35. Brown AK, Conaghan PG, Karim Z et al (2008) An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 58:2958-2967
36. Molenaar ET, Voskuyl AE, Dinant HJ et al (2004) Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum 50:36-42
37. Mulherin D, Fitzgerald O, Bresnihan B (1996) Clinical improvement and radiological deterioration in rheumatoid arthritis: Evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol 35:1263-1268